Tandem Diabetes Care (Nasdaq:TNDM) announced today that its users have delivered more than 1 million insulin boluses using its app.
Users of the t:connect app feature on their personal mobile device have reached the 1 million insulin bolus milestone with the t:slim X2 insulin pump within the first month following its commercial release.
San Diego-based Tandem designed the t:connect mobile app to offer users of the t:slim X2 insulin pump the ability to program and cancel bolus insulin requests through the convenience of their compatible smartphone. The company said in a news release that it is the first-ever FDA-cleared smartphone application capable of initiating insulin delivery on both iOS and Android operating systems. The company added that it is now available on approximately 30 different devices.
Get the full story at our sister site, Drug Delivery Business News.